Internal Medicine Doctors in Bolivar, MO Accepting Medicare

10 Internal Medicine doctors found. Showing 1 - 10

John F Best, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1500 N Oakland Ave, Bolivar, MO 65613 Phone: 417-328-6040    Fax: 417-777-6204

Dr. Penelope Jane Harris, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1501 N Oakland Ave, Bolivar, MO 65613 Phone: 173-267-2004    Fax: 417-326-7201

Dr. Leonid Shunyakov, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1501 N Oakland Ave, Bolivar, MO 65613 Phone: 417-326-7200    Fax: 417-326-7201

Lavonne A Berg, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1551 N. Oakland, Bolivar, MO 65613 Phone: 417-328-6738    Fax: 417-328-6776

Richard A Bertelsen Jr., MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 N Oakland Ave, Bolivar, MO 65613 Phone: 417-326-6000    Fax: 417-328-6341

Dr. Ryan Eugene Denney, D.O Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1155 W Parkview St Ste 1f, Bolivar, MO 65613 Phone: 417-693-0278

Dr. Haris Riaz, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 N Oakland Ave, Bolivar, MO 65613 Phone: 417-328-6040

Dr. Samer Shuaib, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1500 N Oakland Ave, Bolivar, MO 65613 Phone: 417-326-6000

Dr. Joseph Andrew Moore, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1500 N Oakland Ave, Bolivar, MO 65613 Phone: 417-328-6040

Dr. Brian R Robinson, DO Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1155 W Parkview St Ste 2j, Bolivar, MO 65613 Phone: 417-328-7000    Fax: 417-328-1142

News Archive

SOM0226 (tolcapone) drug could significantly improve pharmacological treatment of ATTR

Researchers at the Institute of Biotechnology and Biomedicine, Universitat Autònoma de Barcelona (IBB-UAB), in collaboration with the biopharmaceutical company SOM Biotech, located in the Barcelona Science Park (PCB), have published, in Nature Communications, the results of a drug repositioning study in which they describe a powerful drug, SOM0226 (tolcapone) that could significantly improve the pharmacological treatment of familial transthyretin amyloidosis (ATTR).

Binge drinking causes insulin resistance and increases risk of Type 2 diabetes

Binge drinking causes insulin resistance, which increases the risk of Type 2 diabetes, according to the results of an animal study led by researchers at the Diabetes Obesity and Metabolism Institute at the Icahn School of Medicine at Mount Sinai.

FDA approves two New Drug Applications

Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced that the US Food and Drug Administration (FDA) has approved its first two New Drug Applications (NDAs) based on its proprietary OralXR+(TM) platform technology including the first-ever 24 hour liquid sustained release product.

Finnish research solves family blood mystery

It's the late 1970s, and a man with an unexplained high hemoglobin level (Hb) is referred to Namsos Hospital north of Trondheim, Norway. It turns out that four members of his family have the same condition. Doctor Kjell Kanelønning is the physician who treats the family.

Largest study of women with hyperemesis gravidarum launches in Europe

Women with severe sickness during pregnancy are being invited to join the largest study of the condition in Europe, led by Guy's and St Thomas' NHS Foundation Trust and King's College London.

Read more Medical News

› Verified 7 days ago